Your activity: 38346 p.v.
your limit has been reached. plz Donate us to allow your ip full access, Email: [email protected]

Causes of infection in long-term care facilities: An overview

Causes of infection in long-term care facilities: An overview
Author:
Michael J Richards, MD, FRACP
Section Editor:
Anthony Harris, MD, MPH
Deputy Editor:
Keri K Hall, MD, MS
Literature review current through: Feb 2022. | This topic last updated: Feb 28, 2020.

INTRODUCTION — Long-term care facilities (LTCFs) represent a diverse group of health care settings that serve individuals of all ages and provide variable degrees of care. LTCFs include nursing homes, skilled-nursing facilities providing postacute care, assisted living facilities, retirement homes, rehabilitation centers, long-term care hospitals, long-term psychiatric facilities, and institutions for individuals with intellectual disabilities. For many residents, these facilities are a home as well as a place of nursing, medical, and/or psychosocial care.

LTCFs provide a unique environment for transmission of infection between residents [1-4]. This topic will provide an overview of important infections and pathogens seen in LTCFs. The principles related to infection control in LTCFs are discussed elsewhere. (See "Principles of infection control in long-term care facilities".)

Topic reviews specific to coronavirus disease 2019 (COVID-19) are presented separately. (See "COVID-19: Epidemiology, virology, and prevention" and "COVID-19: Clinical features" and "COVID-19: Diagnosis" and "COVID-19: Infection prevention for persons with SARS-CoV-2 infection".)

TYPES OF INFECTIONS — Important types of infection in LTCFs include respiratory tract infection, gastrointestinal infection, urinary tract infection, and skin and soft tissue infection [5]. Together, these infections represent 94 percent of infections seen in LTCFs [2,3,6,7].

Respiratory tract infection — The incidence of respiratory infections in LTCFs vary widely, ranging from 1.1 to 85.2 percent (influenza 5.9 to 85.2, pneumonia 1.4 to 55.8, and respiratory syncytial virus 1.1 to 13.5) [8,9].

Influenza — Seasonal outbreaks of influenza affecting LTCF residents and staff are common and are associated with substantial morbidity. The challenges of preventing and controlling influenza outbreaks in these settings are well recognized. In a review of 49 outbreaks, median attack rates were 33 percent in residents and 23 percent in staff [10-12]. Older adults may have less typical presentations of influenza, and this limits the opportunities for early recognition and treatment [13]. In addition, increased age is a recognized risk factor for serious infection [12]. Case attack rates may be up to 70 percent, and case fatality rates may be more than 10 percent [13]. (See "Seasonal influenza in adults: Clinical manifestations and diagnosis", section on 'Uncomplicated illness'.)

Annual influenza vaccination for LTCF residents and staff and residents is important for minimizing risk of infection; all residents and staff should be vaccinated [14]. Influenza vaccine and administration of antiviral prophylaxis in outbreak settings are discussed in detail separately. (See "Principles of infection control in long-term care facilities", section on 'Prevention of infection' and "Seasonal influenza in adults: Treatment" and "Prevention of seasonal influenza with antiviral drugs in adults".)

Pneumonia — Mortality due to pneumonia is higher among residents of LTCFs than adults in the community. In addition, an episode of pneumonia in a LTCF resident is associated with increased mortality that persists for up to two years [15]. Predisposing factors include underlying obstructive pulmonary disease, left heart failure, and risk of aspiration [16,17]. Aspiration pneumonia is common in the presence of risk factors including stroke, neuromuscular disorders, or impaired consciousness.

Pneumonia in LTCFs may be caused by pathogens associated with community-acquired pneumonia or hospital-acquired pneumonia. The microbiology depends on whether residents have recently been in an acute care facility and their length of stay in the LTCF. Streptococcus pneumoniae is the most common pathogen [18,19]. Improving pneumococcal vaccination rates is a goal for all adults in LTCFs [20]. (See "Principles of infection control in long-term care facilities", section on 'Prevention of infection'.)

Atypical pathogens such as Mycoplasma pneumoniae are less common in LTCFs than the general community. Gram-negative bacilli are also an important cause of pneumonia in LTCFs [18,21-23].

LTCF residents may be colonized with multidrug-resistant pathogens. One study noted a colonization rate of 51 percent; the isolates included Providencia stuartii, Morganella morganii, Escherichia coli, Proteus mirabilis, Klebsiella pneumoniae, and Enterobacter spp [6]. Risk factors for colonization included dementia and nonambulatory status. Risk factors for pneumonia due to drug-resistant pathogens include antibiotic exposure in the past six months and low Activities of Daily Living score.

Rhinovirus — Rhinovirus is a common cause of respiratory outbreaks in LTCFs [24]. In a Canadian surveillance study, rhinovirus caused 59 percent of respiratory outbreaks during a six-month period in 2009, and disease was sometimes severe [24].

Tuberculosis — Screening for latent tuberculosis (TB) infection (LTBI) among individuals in LTCFs has been a routine practice in the past; subsequently, enthusiasm for routine testing and treatment of LTBI has waned [25,26]. The goal of testing for LTBI is to identify individuals who are at increased risk for the development of TB and therefore would benefit from treatment of LTBI. Testing for LTBI is warranted to identify individuals who are at risk of new infection and to identify individuals at increased risk of reactivation due to associated conditions. The indications and approach for LTBI testing are discussed separately; no modifications to this approach are needed for patients in LTCFs. (See "Approach to diagnosis of latent tuberculosis infection (tuberculosis screening) in adults".)

Studies published in the 1980s suggested a high rate of TB transmission, new infection, and TB disease among older adults in nursing homes. In one study, disease was observed among 5.9 percent of individuals with skin test conversion in the absence of isoniazid therapy [27]. In addition, cohort studies noted lower rates of disease among those who received isoniazid for treatment of LTBI [28,29]. Subsequent studies have not shown comparable rates of infection or disease among LTCF residents, and the benefits of isoniazid appear more modest (with perhaps greater harm) than initially suggested [30-37].

Urinary tract infection — The urinary tract is the most common site of infection among LTCF residents and the most common source of bacteremia; in addition, urinary tract infection (UTI) is the most common reason for administration of antibiotics in LTCFs [38].

Risk factors for UTI include urinary catheters, benign prostatic hypertrophy and prostatitis in men, atrophic vaginitis and estrogen deficiency in women, diabetes, neurogenic bladder, dementia, dehydration, and functional impairment [39-42]. In patients with an indwelling catheter, 50 percent of episodes of fever are from a urinary source [43]. In one report, the incident rate of UTI among LTCF residents was 9.1 per 100 resident-days (among residents with indwelling catheters) and 2.8 per 1000 resident-days (among residents without indwelling catheters) [44]. Nursing home residents with a chronic indwelling catheter are more likely to have multidrug-resistant organisms than residents without those devices [45].

Important steps for prevention of catheter-associated UTI include avoidance of unnecessary catheterization, use of sterile technique for catheter placement, and removal of the catheter as soon as possible. (See "Catheter-associated urinary tract infection in adults", section on 'Prevention'.)

There is no role for screening asymptomatic patients for bacteriuria, as no treatment is indicated in such patients. (See "Asymptomatic bacteriuria in adults".)

Diarrheal disease — Diarrheal illness may spread rapidly in LTCFs; forms of transmission include person to person between residents, contaminated food, and airborne transmission. Residents of LTCFs are estimated to have the highest incidence of diarrhea in the developed world [46]. In the United States, approximately 0.05 to 2.0 episodes of gastroenteritis per 1000 patient days occur among LTCF residents [47]. In Australia between 2002 and 2008, 52 percent of gastroenteritis outbreaks occurred in the nursing home settings; 6.4 percent of patients were hospitalized and 2.7 percent died [48]. Older adults are at increased risk of infection in the setting of decreased gastric acid production, and morbidity and mortality is associated with dehydration [49].

Common etiologies of diarrhea include Clostridioides difficile, norovirus, and salmonella.

C. difficile − Diarrheal illness may be caused by viral or bacterial pathogens. C. difficile is the most common cause of health care-associated diarrhea in resource-rich countries; older adults are affected disproportionately [50]. Among nursing home residents treated with antibiotics in the United States, 8 to 33 percent acquire C. difficile infection (CDI), and 10 to 30 percent of LTCF residents are colonized [51]. The incidence has more than doubled in recent decades [52,53]. Disease severity has also increased especially in those over 60 years of age. Nearly half of health care-onset CDI now occurs in LTCFs [53]. Adequate cleaning of LTCF environments, including removal of spores, is particularly difficult. There is no role for treatment of C. difficile infection in the setting of asymptomatic carriage. Issues related to prevention of C. difficile infection, including environmental cleaning and hand hygiene, are discussed further separately. (See "Clostridioides difficile infection: Prevention and control".)

Norovirus − Norovirus is highly contagious and can be transmitted person to person or via food and water. LTCFs are the most common setting for norovirus outbreaks in the United States [54]. Nearly half of symptomatic patients shed virus for at least 21 days. Norovirus causes over 50 percent of acute gastroenteritis in LTCFs. During outbreaks, all-cause mortality in LTCFs increases.

Other − Other causes of foodborne outbreaks include Salmonella, Staphylococcus, and E. coli O157:H7. In an Australian study of older adult residents of LTCFs between 2005 and 2009, the rates of Salmonella infection were higher, and the rates of toxigenic E. coli, Campylobacter, and Shigella lower, than in community residents [55]. Additional causes of diarrheal outbreaks in LTCFs include Shigella, Yersinia, Giardia, and Cryptosporidium. (See "Causes of acute infectious diarrhea and other foodborne illnesses in resource-rich settings".)

Skin and soft tissue infection — Important skin and soft tissue infections in LTCFs include infection related to pressure ulcers, scabies, and tinea infection.

Pressure ulcers — Pressure ulcers are common in LTCF residents. Most pressure ulcers do not reflect acute infection and do not warrant antibiotic therapy.

Prevention of complications associated with pressure ulcers requires use of support surfaces to minimize pressure, correct patient positioning, regular rotation, and attentive skin care. (See "Prevention of pressure-induced skin and soft tissue injury".)

Issues related to evaluation and management of pressure ulcers are discussed further separately. (See "Clinical staging and management of pressure-induced skin and soft tissue injury".)

Pressure ulcers may be complicated by infection including osteomyelitis and/or bacteremia, especially in immobilized patients. Issues related to evaluation of infectious complications of pressure ulcers are discussed separately. (See "Infectious complications of pressure-induced skin and soft tissue injury".)

Scabies — Scabies outbreaks in LTCFs are common [56]. Scabies infection is associated with itch and rash; in some cases, the index case has crusted scabies, which is characterized by scaly lesions with an enormous mite load. The diagnosis should be confirmed by skin scrapings. Delayed diagnosis may occur in more than 10 percent of patients and is associated with chronic steroid use and long hospitalization [57]. (See "Scabies: Epidemiology, clinical features, and diagnosis", section on 'Crusted scabies'.)

Issues related to control of scabies transmission are discussed separately. (See "Scabies: Management", section on 'Contacts and environment'.)

Tinea infection — Outbreaks of tinea infection can occur and may be perpetuated by contamination of washing areas, linens, or grooming equipment. Measures to control these infections should include prompt treatment of infected individuals, environmental cleaning, and surveillance. (See "Dermatophyte (tinea) infections".)

Conjunctivitis — Conjunctivitis may occur sporadically or in outbreaks and may be caused by bacterial (such as S. aureus) or viral (such as adenovirus) pathogens. The incidence in LTCF was 0.6 to 3.5 per 1000 patient-days in one report [58]. (See "Conjunctivitis".)

Group A streptococcal infection — Outbreaks of group A Streptococcus (GAS) infection in LTCFs have been described [59,60]. In one review including 1762 cases of invasive GAS infection, the incidence among LTCF residents (compared with community-based older adults) was 41 versus 7 cases per 100,000 population [59]. Patients in LTCFs were 1.5 times as likely to die from the infection as community-based patients (33 versus 21 percent). Outbreaks may occur over a long period of time, be challenging to identify, and can originate from an asymptomatic carrier [61].

Transmission is predominantly person to person, particularly via direct contact between residents.

Clinical syndromes due to GAS include cellulitis, toxic shock syndrome, pharyngitis, bronchitis, pneumonia, and bacteremia. These are discussed further separately. (See "Treatment and prevention of streptococcal pharyngitis in adults and children" and "Invasive group A streptococcal infection and toxic shock syndrome: Epidemiology, clinical manifestations, and diagnosis".)

Bloodborne and sexually transmitted pathogens — Transmission of HIV, hepatitis B, and hepatitis C in LTCFs can occur; both bloodborne and sexual transmission have been described [62]. Patients with severe mental illness in LTCFs may have a high incidence of hepatitis B and HIV infection. (See "Management of health care personnel exposed to HIV" and "Management of nonoccupational exposures to HIV and hepatitis B and C in adults" and "Prevention of hepatitis B virus and hepatitis C virus infection among health care providers".)

Issues related to safe injection practices are described separately. (See "Infection control in the outpatient setting", section on 'Safe injection practices'.)

ANTIMICROBIAL-RESISTANT ORGANISMS — Multidrug-resistant organisms (MDROs) are more common in LTCFs in the United States than in acute care setting [63,64]. Over 35 percent of United States nursing home residents are colonized with MDROs [64,65]. Many residents have extensive histories of health care exposure, indwelling devices, and the environment poses challenges to infection prevention [66]. Often, there is also considerable antibiotic overuse. Organisms may be transferred between acute and long-term care facilities via LTCF residents, and transmission can occur via contact with colonized skin or fecal-oral transmission.

Methicillin-resistant S. aureus — Approximately 10 to 50 percent of LTCF residents in United States are colonized with methicillin-resistant S. aureus (MRSA); one study including 412 residents reported a MRSA prevalence rate of 58 percent [67]. Risk factors for MRSA colonization in LTCFs include antimicrobial use, dependence on health care personnel for assistance with activities of daily living, presence of decubitus ulcers, and renal insufficiency [68,69].

Issues related to prevention and control of MRSA are discussed further separately. (See "Methicillin-resistant Staphylococcus aureus (MRSA) in adults: Prevention and control".)

Vancomycin-resistant Enterococcus — The colonization rate of vancomycin-resistant Enterococcus (VRE) in LTCFs is variable. One study including 100 residents of 20 different LTCFs admitted to an acute care hospital noted 45 percent of patients were colonized with VRE on admission [70]. Another study including 1215 LTCF residents noted a VRE carriage rate of 9.6 percent [71].

Issues related to prevention of VRE infection are discussed further separately. (See "Vancomycin-resistant enterococci: Epidemiology, prevention, and control".)

Pneumococcus — In South Korea, ceftriaxone non-susceptible pneumococcal isolates accounted for 35 percent of pneumococci, and on multivariate analysis, LTCF residence was a risk factor (odds ratio 7.0, 95% CI 0.8-62.1) [72].

Drug-resistant gram-negative organisms — Residents of LTCFs are at increased risk for acquisition of multidrug-resistant gram-negative bacteria (defined as resistance to three or more different antimicrobial classes), which are associated with prior antibiotic use [6,73-76]. LTCFs may serve as reservoirs for these organisms; in some facilities, colonization rates with these strains are comparable with or higher than colonization rates in acute care hospitals [75-80]. Colonization with a variety of resistant gram-negative bacteria have been reported, including fluoroquinolone-resistant E. coli, extended-spectrum beta-lactamase E. coli, multidrug-resistant Acinetobacter baumannii, and carbapenem-resistant Enterobacteriaceae. Ventilator use, fecal incontinence, and urinary catheterization were associated with increased risk.

The use of bundled intervention for prevention of infection due to drug-resistant gram-negative organisms is discussed separately. (See "Principles of infection control in long-term care facilities", section on 'Bundled interventions'.)

SUMMARY

Causes of infection in long-term care facilities (LTCFs) include respiratory infection, diarrheal disease, urinary tract infection, and skin and soft tissue infections. (See 'Types of infections' above.)

Seasonal outbreaks of influenza are common and affect residents as well as staff. (See 'Influenza' above.)

Risk factors for pneumonia include chronic pulmonary disease, heart failure, and aspiration. Pathogens include organisms associated with community-acquired pneumonia and hospital-acquired pneumonia. (See 'Pneumonia' above.)

The urinary tract is the most common site of infection among LTCF residents and the most common source of bacteremia. Urinary tract infections in LTCFs are often associated with urethral catheterization. There is no role for screening asymptomatic patients for bacteriuria. (See 'Urinary tract infection' above.)

Diarrheal illness may be caused by viral or bacterial pathogens. Clostridioides difficile is the most common cause of health care-associated diarrhea in resource-rich countries. Norovirus is highly contagious and can be transmitted person to person or via food and water. Other causes of foodborne outbreaks include Salmonella, Staphylococcus, and Escherichia coli O157:H7. (See 'Diarrheal disease' above.)

Antimicrobial-resistant organisms are increasingly recognized in LTCFs. Organisms may be transferred between acute and long-term care facilities via LTCF residents, and transmission can occur via contact with colonized skin or fecal-oral transmission. (See 'Antimicrobial-resistant organisms' above.)

ACKNOWLEDGMENT — The UpToDate editorial staff acknowledges Rhonda Stuart, MD, who contributed to an earlier version of this topic review.

REFERENCES

  1. High KP, Bradley SF, Gravenstein S, et al. Clinical practice guideline for the evaluation of fever and infection in older adult residents of long-term care facilities: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48:149.
  2. Heudorf U, Boehlcke K, Schade M. Healthcare-associated infections in long-term care facilities (HALT) in Frankfurt am Main, Germany, January to March 2011. Euro Surveill 2012; 17.
  3. Cotter M, Donlon S, Roche F, et al. Healthcare-associated infection in Irish long-term care facilities: results from the First National Prevalence Study. J Hosp Infect 2012; 80:212.
  4. Smith PW, Bennett G, Bradley S, et al. SHEA/APIC guideline: infection prevention and control in the long-term care facility, July 2008. Infect Control Hosp Epidemiol 2008; 29:785.
  5. Montoya A, Mody L. Common infections in nursing homes: a review of current issues and challenges. Aging health 2011; 7:889.
  6. Pop-Vicas A, Mitchell SL, Kandel R, et al. Multidrug-resistant gram-negative bacteria in a long-term care facility: prevalence and risk factors. J Am Geriatr Soc 2008; 56:1276.
  7. Engelhart ST, Hanses-Derendorf L, Exner M, Kramer MH. Prospective surveillance for healthcare-associated infections in German nursing home residents. J Hosp Infect 2005; 60:46.
  8. Bosco E, Zullo AR, McConeghy KW, et al. Long-term Care Facility Variation in the Incidence of Pneumonia and Influenza. Open Forum Infect Dis 2019; 6:ofz230.
  9. Childs A, Zullo AR, Joyce NR, et al. The burden of respiratory infections among older adults in long-term care: a systematic review. BMC Geriatr 2019; 19:210.
  10. Rainwater-Lovett K, Chun K, Lessler J. Influenza outbreak control practices and the effectiveness of interventions in long-term care facilities: a systematic review. Influenza Other Respir Viruses 2014; 8:74.
  11. Cheng HY, Chen WC, Chou YJ, et al. Containing influenza outbreaks with antiviral use in long-term care facilities in Taiwan, 2008-2014. Influenza Other Respir Viruses 2018; 12:287.
  12. Lansbury LE, Brown CS, Nguyen-Van-Tam JS. Influenza in long-term care facilities. Influenza Other Respir Viruses 2017; 11:356.
  13. Pop-Vicas A, Gravenstein S. Influenza in the elderly: a mini-review. Gerontology 2011; 57:397.
  14. World Health Organization. Prevention and control of outbreaks of seasonal influenza in long-term care facilities: A review of the evidence and best-practice guidance. http://www.euro.who.int/__data/assets/pdf_file/0015/330225/LTCF-best-practice-guidance.pdf?ua=1 (Accessed on September 04, 2017).
  15. Vergis EN, Brennen C, Wagener M, Muder RR. Pneumonia in long-term care: a prospective case-control study of risk factors and impact on survival. Arch Intern Med 2001; 161:2378.
  16. Medina-Walpole AM, Katz PR. Nursing home-acquired pneumonia. J Am Geriatr Soc 1999; 47:1005.
  17. Marik PE, Kaplan D. Aspiration pneumonia and dysphagia in the elderly. Chest 2003; 124:328.
  18. Polverino E, Dambrava P, Cillóniz C, et al. Nursing home-acquired pneumonia: a 10 year single-centre experience. Thorax 2010; 65:354.
  19. Polverino E, Torres A, Menendez R, et al. Microbial aetiology of healthcare associated pneumonia in Spain: a prospective, multicentre, case-control study. Thorax 2013; 68:1007.
  20. Stevenson CG, McArthur MA, Naus M, et al. Prevention of influenza and pneumococcal pneumonia in Canadian long-term care facilities: how are we doing? CMAJ 2001; 164:1413.
  21. Ewig S, Klapdor B, Pletz MW, et al. Nursing-home-acquired pneumonia in Germany: an 8-year prospective multicentre study. Thorax 2012; 67:132.
  22. Carusone SC, Loeb M, Lohfeld L. Pneumonia care and the nursing home: a qualitative descriptive study of resident and family member perspectives. BMC Geriatr 2006; 6:2.
  23. Fukuyama H, Yamashiro S, Tamaki H, Kishaba T. A prospective comparison of nursing- and healthcare-associated pneumonia (NHCAP) with community-acquired pneumonia (CAP). J Infect Chemother 2013; 19:719.
  24. Longtin J, Marchand-Austin A, Winter AL, et al. Rhinovirus outbreaks in long-term care facilities, Ontario, Canada. Emerg Infect Dis 2010; 16:1463.
  25. Jensen PA, Lambert LA, Iademarco MF, et al. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep 2005; 54:1.
  26. Finucane TE. The American Geriatrics Society statement on two-step PPD testing for nursing home patients on admission. J Am Geriatr Soc 1988; 36:77.
  27. Stead WW, Lofgren JP, Warren E, Thomas C. Tuberculosis as an endemic and nosocomial infection among the elderly in nursing homes. N Engl J Med 1985; 312:1483.
  28. Stead WW, To T, Harrison RW, Abraham JH 3rd. Benefit-risk considerations in preventive treatment for tuberculosis in elderly persons. Ann Intern Med 1987; 107:843.
  29. Stead WW. Isoniazid prophylaxis. Ann Intern Med 1981; 95:393.
  30. Verma G, Chuck AW, Jacobs P. Tuberculosis screening for long-term care: a cost-effectiveness analysis. Int J Tuberc Lung Dis 2013; 17:1170.
  31. Smith BM, Schwartzman K, Bartlett G, Menzies D. Adverse events associated with treatment of latent tuberculosis in the general population. CMAJ 2011; 183:E173.
  32. Chan-Yeung M, Chan FH, Cheung AH, et al. Prevalence of tuberculous infection and active tuberculosis in old age homes in Hong Kong. J Am Geriatr Soc 2006; 54:1334.
  33. Borgdorff MW, Nagelkerke NJ, de Haas PE, van Soolingen D. Transmission of Mycobacterium tuberculosis depending on the age and sex of source cases. Am J Epidemiol 2001; 154:934.
  34. Naglie G, McArthur M, Simor A, et al. Tuberculosis surveillance practices in long-term care institutions. Infect Control Hosp Epidemiol 1995; 16:148.
  35. Macarthur C, Enarson DA, Fanning EA, et al. Tuberculosis among institutionalized elderly in Alberta, Canada. Int J Epidemiol 1992; 21:1175.
  36. Marchand RS, Tousignant P. [Tuberculosis in aged persons residing in Quebec facilities: are screening and chemoprophylaxis indicated?]. Can J Public Health 1995; 86:238.
  37. Hutton MD, Cauthen GM, Bloch AB. Results of a 29-state survey of tuberculosis in nursing homes and correctional facilities. Public Health Rep 1993; 108:305.
  38. Nicolle LE, SHEA Long-Term-Care-Committee. Urinary tract infections in long-term-care facilities. Infect Control Hosp Epidemiol 2001; 22:167.
  39. Wong ES, Hooton TM. Guideline for prevention of catheter-associated urinary tract infections. Infect Control 1981; 2:125.
  40. Nicolle LE. The chronic indwelling catheter and urinary infection in long-term-care facility residents. Infect Control Hosp Epidemiol 2001; 22:316.
  41. McNulty C, Freeman E, Smith G, et al. Prevalence of urinary catheterization in UK nursing homes. J Hosp Infect 2003; 55:119.
  42. Tsan L, Langberg R, Davis C, et al. Nursing home-associated infections in Department of Veterans Affairs community living centers. Am J Infect Control 2010; 38:461.
  43. Wang L, Lansing B, Symons K, et al. Infection rate and colonization with antibiotic-resistant organisms in skilled nursing facility residents with indwelling devices. Eur J Clin Microbiol Infect Dis 2012; 31:1797.
  44. Wang L, Lansing B. Attributable rates of infections due to indwelling device use in skilled nursing facilities. SHEA Meeting Presentation, April 4, 2011.
  45. Terpenning MS, Bradley SF, Wan JY, et al. Colonization and infection with antibiotic-resistant bacteria in a long-term care facility. J Am Geriatr Soc 1994; 42:1062.
  46. Archbald-Pannone LR, Boone JH, Carman RJ, et al. Clostridium difficile ribotype 027 is most prevalent among inpatients admitted from long-term care facilities. J Hosp Infect 2014; 88:218.
  47. Jacobson C, Strausbaugh LJ. Incidence and impact of infection in a nursing home care unit. Am J Infect Control 1990; 18:151.
  48. Kirk MD, Fullerton KE, Hall GV, et al. Surveillance for outbreaks of gastroenteritis in long-term care facilities, Australia, 2002-2008. Clin Infect Dis 2010; 51:907.
  49. Frenzen PD. Deaths due to unknown foodborne agents. Emerg Infect Dis 2004; 10:1536.
  50. Simor AE. Diagnosis, management, and prevention of Clostridium difficile infection in long-term care facilities: a review. J Am Geriatr Soc 2010; 58:1556.
  51. Makris AT, Gelone S. Clostridium difficile in the long-term care setting. J Am Med Dir Assoc 2007; 8:290.
  52. Zilberberg MD. Clostridium difficile-related hospitalizations among US adults, 2006. Emerg Infect Dis 2009; 15:122.
  53. Ziakas PD, Joyce N, Zacharioudakis IM, et al. Prevalence and impact of Clostridium difficile infection in elderly residents of long-term care facilities, 2011: A nationwide study. Medicine (Baltimore) 2016; 95:e4187.
  54. Costantini VP, Cooper EM, Hardaker HL, et al. Epidemiologic, Virologic, and Host Genetic Factors of Norovirus Outbreaks in Long-term Care Facilities. Clin Infect Dis 2016; 62:1.
  55. Kirk MD, Gregory J, Lalor K, et al. Foodborne and waterborne infections in elderly community and long-term care facility residents,Victoria, Australia. Emerg Infect Dis 2012; 18:377.
  56. Estes SA, Estes J. Therapy of scabies: nursing homes, hospitals, and the homeless. Semin Dermatol 1993; 12:26.
  57. Lay CJ, Wang CL, Chuang HY, et al. Risk factors for delayed diagnosis of scabies in hospitalized patients from long-term care facilities. J Clin Med Res 2011; 3:72.
  58. Boustcha E, Nicolle LE. Conjunctivitis in a long-term care facility. Infect Control Hosp Epidemiol 1995; 16:210.
  59. Thigpen MC, Richards CL Jr, Lynfield R, et al. Invasive group A streptococcal infection in older adults in long-term care facilities and the community, United States, 1998-2003. Emerg Infect Dis 2007; 13:1852.
  60. Jordan HT, Richards CL Jr, Burton DC, et al. Group a streptococcal disease in long-term care facilities: descriptive epidemiology and potential control measures. Clin Infect Dis 2007; 45:742.
  61. Pilon PA, Savard N, Aho J, et al. Invasive group A streptococcal infection outbreaks of typeemm118 in a long-term care facility, and of type emm74 in the homeless population, Montréal, Quebec. Can Commun Dis Rep 2019; 45:26.
  62. Jasuja S, Thompson ND, Peters PJ, et al. Investigation of hepatitis B virus and human immunodeficiency virus transmission among severely mentally ill residents at a long term care facility. PLoS One 2012; 7:e43252.
  63. Mody L, Foxman B, Bradley S, et al. Longitudinal Assessment of Multidrug-Resistant Organisms in Newly Admitted Nursing Facility Patients: Implications for an Evolving Population. Clin Infect Dis 2018; 67:837.
  64. Cassone M, Mody L. Colonization with Multi-Drug Resistant Organisms in Nursing Homes: Scope, Importance, and Management. Curr Geriatr Rep 2015; 4:87.
  65. Fisch J, Lansing B, Wang L, et al. New acquisition of antibiotic-resistant organisms in skilled nursing facilities. J Clin Microbiol 2012; 50:1698.
  66. Katz MJ, Roghmann MC. Healthcare-associated infections in the elderly: what's new. Curr Opin Infect Dis 2016; 29:388.
  67. Stone ND, Lewis DR, Johnson TM 2nd, et al. Methicillin-resistant Staphylococcus aureus (MRSA) nasal carriage in residents of Veterans Affairs long-term care facilities: role of antimicrobial exposure and MRSA acquisition. Infect Control Hosp Epidemiol 2012; 33:551.
  68. Manzur A, Gudiol F. Methicillin-resistant Staphylococcus aureus in long-term-care facilities. Clin Microbiol Infect 2009; 15 Suppl 7:26.
  69. Garazi M, Edwards B, Caccavale D, et al. Nursing homes as reservoirs of MRSA: myth or reality? J Am Med Dir Assoc 2009; 10:414.
  70. Elizaga ML, Weinstein RA, Hayden MK. Patients in long-term care facilities: a reservoir for vancomycin-resistant enterococci. Clin Infect Dis 2002; 34:441.
  71. Benenson S, Cohen MJ, Block C, et al. Vancomycin-resistant enterococci in long-term care facilities. Infect Control Hosp Epidemiol 2009; 30:786.
  72. Choi MJ, Noh JY, Cheong HJ, et al. Spread of ceftriaxone non-susceptible pneumococci in South Korea: Long-term care facilities as a potential reservoir. PLoS One 2019; 14:e0210520.
  73. O'Fallon E, Kandel R, Schreiber R, D'Agata EM. Acquisition of multidrug-resistant gram-negative bacteria: incidence and risk factors within a long-term care population. Infect Control Hosp Epidemiol 2010; 31:1148.
  74. Tinelli M, Cataldo MA, Mantengoli E, et al. Epidemiology and genetic characteristics of extended-spectrum β-lactamase-producing Gram-negative bacteria causing urinary tract infections in long-term care facilities. J Antimicrob Chemother 2012; 67:2982.
  75. Lin MY, Lyles-Banks RD, Lolans K, et al. The importance of long-term acute care hospitals in the regional epidemiology of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis 2013; 57:1246.
  76. Prabaker K, Lin MY, McNally M, et al. Transfer from high-acuity long-term care facilities is associated with carriage of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae: a multihospital study. Infect Control Hosp Epidemiol 2012; 33:1193.
  77. Burgess MJ, Johnson JR, Porter SB, et al. Long-Term Care Facilities Are Reservoirs for Antimicrobial-Resistant Sequence Type 131 Escherichia coli. Open Forum Infect Dis 2015; 2:ofv011.
  78. Han JH, Maslow J, Han X, et al. Risk factors for the development of gastrointestinal colonization with fluoroquinolone-resistant Escherichia coli in residents of long-term care facilities. J Infect Dis 2014; 209:420.
  79. Mortensen E, Trivedi KK, Rosenberg J, et al. Multidrug-resistant Acinetobacter baumannii infection, colonization, and transmission related to a long-term care facility providing subacute care. Infect Control Hosp Epidemiol 2014; 35:406.
  80. Suetens C, Latour K, Kärki T, et al. Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017. Euro Surveill 2018; 23.
Topic 3809 Version 31.0

References

1 : Clinical practice guideline for the evaluation of fever and infection in older adult residents of long-term care facilities: 2008 update by the Infectious Diseases Society of America.

2 : Healthcare-associated infections in long-term care facilities (HALT) in Frankfurt am Main, Germany, January to March 2011.

3 : Healthcare-associated infection in Irish long-term care facilities: results from the First National Prevalence Study.

4 : SHEA/APIC guideline: infection prevention and control in the long-term care facility, July 2008.

5 : Common infections in nursing homes: a review of current issues and challenges.

6 : Multidrug-resistant gram-negative bacteria in a long-term care facility: prevalence and risk factors.

7 : Prospective surveillance for healthcare-associated infections in German nursing home residents.

8 : Long-term Care Facility Variation in the Incidence of Pneumonia and Influenza.

9 : The burden of respiratory infections among older adults in long-term care: a systematic review.

10 : Influenza outbreak control practices and the effectiveness of interventions in long-term care facilities: a systematic review.

11 : Containing influenza outbreaks with antiviral use in long-term care facilities in Taiwan, 2008-2014.

12 : Influenza in long-term care facilities.

13 : Influenza in the elderly: a mini-review.

14 : Influenza in the elderly: a mini-review.

15 : Pneumonia in long-term care: a prospective case-control study of risk factors and impact on survival.

16 : Nursing home-acquired pneumonia.

17 : Aspiration pneumonia and dysphagia in the elderly.

18 : Nursing home-acquired pneumonia: a 10 year single-centre experience.

19 : Microbial aetiology of healthcare associated pneumonia in Spain: a prospective, multicentre, case-control study.

20 : Prevention of influenza and pneumococcal pneumonia in Canadian long-term care facilities: how are we doing?

21 : Nursing-home-acquired pneumonia in Germany: an 8-year prospective multicentre study.

22 : Pneumonia care and the nursing home: a qualitative descriptive study of resident and family member perspectives.

23 : A prospective comparison of nursing- and healthcare-associated pneumonia (NHCAP) with community-acquired pneumonia (CAP).

24 : Rhinovirus outbreaks in long-term care facilities, Ontario, Canada.

25 : Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005.

26 : The American Geriatrics Society statement on two-step PPD testing for nursing home patients on admission.

27 : Tuberculosis as an endemic and nosocomial infection among the elderly in nursing homes.

28 : Benefit-risk considerations in preventive treatment for tuberculosis in elderly persons.

29 : Isoniazid prophylaxis.

30 : Tuberculosis screening for long-term care: a cost-effectiveness analysis.

31 : Adverse events associated with treatment of latent tuberculosis in the general population.

32 : Prevalence of tuberculous infection and active tuberculosis in old age homes in Hong Kong.

33 : Transmission of Mycobacterium tuberculosis depending on the age and sex of source cases.

34 : Tuberculosis surveillance practices in long-term care institutions.

35 : Tuberculosis among institutionalized elderly in Alberta, Canada.

36 : [Tuberculosis in aged persons residing in Quebec facilities: are screening and chemoprophylaxis indicated?].

37 : Results of a 29-state survey of tuberculosis in nursing homes and correctional facilities.

38 : Urinary tract infections in long-term-care facilities.

39 : Guideline for prevention of catheter-associated urinary tract infections

40 : The chronic indwelling catheter and urinary infection in long-term-care facility residents.

41 : Prevalence of urinary catheterization in UK nursing homes.

42 : Nursing home-associated infections in Department of Veterans Affairs community living centers.

43 : Infection rate and colonization with antibiotic-resistant organisms in skilled nursing facility residents with indwelling devices.

44 : Infection rate and colonization with antibiotic-resistant organisms in skilled nursing facility residents with indwelling devices.

45 : Colonization and infection with antibiotic-resistant bacteria in a long-term care facility.

46 : Clostridium difficile ribotype 027 is most prevalent among inpatients admitted from long-term care facilities.

47 : Incidence and impact of infection in a nursing home care unit.

48 : Surveillance for outbreaks of gastroenteritis in long-term care facilities, Australia, 2002-2008.

49 : Deaths due to unknown foodborne agents.

50 : Diagnosis, management, and prevention of Clostridium difficile infection in long-term care facilities: a review.

51 : Clostridium difficile in the long-term care setting.

52 : Clostridium difficile-related hospitalizations among US adults, 2006.

53 : Prevalence and impact of Clostridium difficile infection in elderly residents of long-term care facilities, 2011: A nationwide study.

54 : Epidemiologic, Virologic, and Host Genetic Factors of Norovirus Outbreaks in Long-term Care Facilities.

55 : Foodborne and waterborne infections in elderly community and long-term care facility residents,Victoria, Australia.

56 : Therapy of scabies: nursing homes, hospitals, and the homeless.

57 : Risk factors for delayed diagnosis of scabies in hospitalized patients from long-term care facilities.

58 : Conjunctivitis in a long-term care facility.

59 : Invasive group A streptococcal infection in older adults in long-term care facilities and the community, United States, 1998-2003.

60 : Group a streptococcal disease in long-term care facilities: descriptive epidemiology and potential control measures.

61 : Invasive group A streptococcal infection outbreaks of typeemm118 in a long-term care facility, and of type emm74 in the homeless population, Montréal, Quebec.

62 : Investigation of hepatitis B virus and human immunodeficiency virus transmission among severely mentally ill residents at a long term care facility.

63 : Longitudinal Assessment of Multidrug-Resistant Organisms in Newly Admitted Nursing Facility Patients: Implications for an Evolving Population.

64 : Colonization with Multi-Drug Resistant Organisms in Nursing Homes: Scope, Importance, and Management.

65 : New acquisition of antibiotic-resistant organisms in skilled nursing facilities.

66 : Healthcare-associated infections in the elderly: what's new.

67 : Methicillin-resistant Staphylococcus aureus (MRSA) nasal carriage in residents of Veterans Affairs long-term care facilities: role of antimicrobial exposure and MRSA acquisition.

68 : Methicillin-resistant Staphylococcus aureus in long-term-care facilities.

69 : Nursing homes as reservoirs of MRSA: myth or reality?

70 : Patients in long-term care facilities: a reservoir for vancomycin-resistant enterococci.

71 : Vancomycin-resistant enterococci in long-term care facilities.

72 : Spread of ceftriaxone non-susceptible pneumococci in South Korea: Long-term care facilities as a potential reservoir.

73 : Acquisition of multidrug-resistant gram-negative bacteria: incidence and risk factors within a long-term care population.

74 : Epidemiology and genetic characteristics of extended-spectrumβ-lactamase-producing Gram-negative bacteria causing urinary tract infections in long-term care facilities.

75 : The importance of long-term acute care hospitals in the regional epidemiology of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae.

76 : Transfer from high-acuity long-term care facilities is associated with carriage of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae: a multihospital study.

77 : Long-Term Care Facilities Are Reservoirs for Antimicrobial-Resistant Sequence Type 131 Escherichia coli.

78 : Risk factors for the development of gastrointestinal colonization with fluoroquinolone-resistant Escherichia coli in residents of long-term care facilities.

79 : Multidrug-resistant Acinetobacter baumannii infection, colonization, and transmission related to a long-term care facility providing subacute care.

80 : Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017.